Quarterly report pursuant to Section 13 or 15(d)

EQUITY TRANSACTIONS (Details 1)

v3.7.0.1
EQUITY TRANSACTIONS (Details 1)
6 Months Ended
Jun. 30, 2017
$ / shares
shares
Equity Transactions Details 1  
Number of Options Outstanding, Beginning | shares 1,124,900
Number of Options Granted | shares 189,159
Number of Options Outstanding, Ending | shares 1,314,059
Number of Options Outstanding, Exercisable | shares 668,490
Weighted Average Exercise Price Outstanding, Beginning | $ / shares $ 2.15
Weighted Average Exercise Price Granted | $ / shares 1.15
Weighted Average Exercise Price Outstanding, Ending | $ / shares 2.01
Weighted Average Exercise Price Outstanding, Exercisable | $ / shares $ 3.95
Weighted Average Remaining Term, Outstanding 9 years
Weighted Average Remaining Term, Granted 9 years 7 months 13 days
Weighted Average Remaining Term, Outstanding 8 years 8 months 12 days
Weighted Average Remaining Term, Exercisable 8 years 5 months 8 days